Q2 FY2026 EarningsQ2 FY26 results significantly outperformed consensus expectations across all profitability metrics. Revenue reached $343.6K, exceeding the $0.00 consensus estimate driven by the commercial scale-up of Arbli™ and the launch of REZENOPY™. GAAP Net Loss of $2.8M was 20% narrower than the $3.5M expected, while Diluted EPS of -$0.07 beat the -$0.09 consensus. Management signaled a clear path to profitability by 2027, backed by a strengthened cash position of $11.2M.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Scienture(SCNX) the Revenue is 335.78 K (--%), Beat estimate;the EBIT is -2.7 M (--%), Beat estimate;the EPS is -0.07 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B--
0.00B--
+0.00B--%
EBITExceed expectations
-0.00B--
-0.00B--
+0.00B--%
EPSExceed expectations
-0.07--
-0.09--
+0.0200--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf